Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-Expressing Oncolytic Virus
Molecular Therapy - United States
doi 10.1038/mt.2011.208
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
Elsevier BV